Sayre Therapeutics was founded in 2015 backed by leading institutional investors.
The team boasts 25 years of global executive experience in leading Pharmaceutical, Medical Diagnostics & Devices companies. Sayre Therapeutics has been identified as a high potential healthcare company, a pedigree team with proven wins and a robust clinician network in the Oncology / Immunology space. The company is uniquely positioned with a first-mover advantage, which allows for it to quickly create a portfolio of differentiated global assets in emerging markets.
Sayre is backed by two leading venture capital firms (VCs).
Our geographic footprint covers India, South Asian and South-East Asian countries which are witnessing a high growth rate across the disease areas of interest. Sayre Therapeutics with its focused strategy, strong financial backing and established relationships with clinicians and regulatory know-how, will be nimble and to that end, will prove to be a committed partner to licensors for their global assets.
We will become Asia’s specialized healthcare company of choice, providing patients and clinicians access to high-quality novel medical solutions for life-threatening diseases.
We facilitate access to differentiated medical solutions to patients and clinicians in emerging markets by identifying high unmet needs across the healthcare continuum. We engage with global partners and customers, enabling commercial innovations through strategy and superior science, to drive profitable growth.
Shukrit Sudhir ChimoteChief Executive Officer
Shukrit has a proven track record in the pharmaceutical industry and prior to founding Sayre Therapeutics, he served as Vice-President and India / South-Asia Head, Branded Formulations at Biocon, Bangalore, India. His responsibilities spanned the breadth of commercial operations including P&L management. Additionally, he headed global business development for the vertical, and directed strategies across eight business units, driving global in-licensing for them. His earlier roles at the premier Indian biotech included heading the Novel Medicines out-licensing and Biosimilars’ verticals.
Shukrit’ s experience set over twenty five years in corporate and academia covers R&D strategy, analytics/market-research, global and in-line marketing and global business development. Shukrit is credited with building robust business lines in India, and drove the commercial strategy for global brands in the US.
Shukrit completed his Bachelor’s degree in Pharmacy from Mumbai, India and his MS in Pharmacology & an MBA in Pharmaceutical marketing from the University of Mississippi, US. He also has a Masters in International affairs from SIPA @ Columbia University, New York. He is married with two kids. Loves sushi and poha, keeps abreast of current political affairs, dreams of being fit and is a voracious TV watcher.
Dr Ravindranath KunjithaiVice President & Head– Medical and Regulatory Affairs
He leads a team that is responsible for providing scientific communication regarding the products, lead/conduct clinical trials, provide medical information/education, and guide products through the regulatory pathway. Prior to his role in Sayre Therapeutics Ravi held a leadership role in Novartis Healthcare in its Global Medical Operations in India.
Before that Ravi was part of the well-known Indian Biotech company – Biocon, as a Medical Director. Ravi was responsible for managing the Medical Affairs team of the company. The highlights of his tenure in this organization were building an effective MSL team and successful launching pens for administration of insulin.
Ravi loves to travel with his family and capture his unique experiences in his camera. Enjoys reading, running and fiddling with gizmos.